Navana Pharmaceuticals Income Statement

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	9,520	8,843	6,898	5,706	4,759	3,607
Revenue Growth (YoY)	28.58%	28.19%	20.89%	19.91%	31.95%	14.53%
Cost of Revenue	5,404	4,965	3,770	3,110	2,599	1,993
Gross Profit	4,116	3,878	3,128	2,596	2,160	1,614
Selling, General & Admin	2,650	2,432	2,136	1,841	1,591	1,265
Operating Expenses	2,650	2,432	2,136	1,841	1,591	1,265
Operating Income	1,466	1,446	991.84	755.72	569.6	348.59
Interest Expense	-665.23	-726.63	-463.57	-234.89	-200.42	-75.18
Interest & Investment Income	1.4	1.07	1.47	5.84	5.58	0.03
Currency Exchange Gain (Loss)	-47.02	-54.08	-25.18	-33.38	-93.98	-2.52
Other Non Operating Income (Expenses)	21.13	6.15	11.39	-1.91	27.64	30.47
EBT Excluding Unusual Items	776.58	672.48	515.95	491.38	308.42	301.39
Gain (Loss) on Sale of Investments	-	-10.46	-0.88	-42.3	82.9	-
Gain (Loss) on Sale of Assets	-0.09	-0.09	1.18	-	0.47	1.02
Pretax Income	776.49	661.93	516.25	449.08	391.79	302.41
Income Tax Expense	238.74	174.12	111.62	92.14	117.78	100.12
Net Income	537.75	487.81	404.63	356.94	274	202.29
Net Income to Common	537.75	487.81	404.63	356.94	274	202.29
Net Income Growth	28.39%	20.56%	13.36%	30.27%	35.45%	47.23%
Shares Outstanding (Basic)	108	107	107	99	80	80
Shares Outstanding (Diluted)	108	107	107	99	80	80
Shares Change (YoY)	0.56%	-	8.05%	23.91%	-	-
EPS (Basic)	5.00	4.54	3.77	3.59	3.42	2.52
EPS (Diluted)	4.99	4.54	3.77	3.59	3.42	2.52
EPS Growth	27.59%	20.56%	4.92%	5.13%	35.45%	47.23%
Free Cash Flow	1,907	1,444	-625.1	-1,404	-1,160	-399
Free Cash Flow Per Share	17.69	13.44	-5.82	-14.13	-14.45	-4.97
Dividend Per Share	1.400	1.400	1.400	1.300	1.100	-
Dividend Growth	-	-	7.69%	18.18%	-	-
Gross Margin	43.23%	43.85%	45.34%	45.50%	45.39%	44.75%
Operating Margin	15.40%	16.35%	14.38%	13.24%	11.97%	9.66%
Profit Margin	5.65%	5.52%	5.87%	6.25%	5.76%	5.61%
Free Cash Flow Margin	20.03%	16.33%	-9.06%	-24.61%	-24.37%	-11.06%
EBITDA	1,744	1,715	1,163	966.13	675.37	397.71
EBITDA Margin	18.32%	19.39%	16.86%	16.93%	14.19%	11.03%
D&A For EBITDA	277.99	268.77	171.25	210.41	105.77	49.12
EBIT	1,466	1,446	991.84	755.72	569.6	348.59
EBIT Margin	15.40%	16.35%	14.38%	13.24%	11.97%	9.66%
Effective Tax Rate	30.75%	26.30%	21.62%	20.52%	30.06%	33.11%
Advertising Expenses	-	42.15	38.4	33.13	80.86	19.55

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.